Table 5.

Odds ratios for IHD and ICVD by MTHFR C677T genotype in case-control studies



IHD

ICVD

Odds ratio (95% CI)
Trend test, P
Odds ratio (95% CI)
Trend test, P
Unadjusted     
    Noncarriers   1.0   .84   1.0   .72  
    Heterozygotes   0.9 (0.8-1.0)   .84   1.0 (0.8-1.1)   .72  
    Homozygotes   1.1 (0.9-1.3)   .84   1.0 (0.8-1.3)   .72  
Adjusted for age and sex     
    Noncarriers   1.0   .66   1.0   .83  
    Heterozygotes   0.9 (0.8-1.0)   .66   1.0 (0.8-1.2)   .83  
    Homozygotes
 
1.0 (0.9-1.3)
 
.66
 
1.0 (0.7-1.3)
 
.83
 


IHD

ICVD

Odds ratio (95% CI)
Trend test, P
Odds ratio (95% CI)
Trend test, P
Unadjusted     
    Noncarriers   1.0   .84   1.0   .72  
    Heterozygotes   0.9 (0.8-1.0)   .84   1.0 (0.8-1.1)   .72  
    Homozygotes   1.1 (0.9-1.3)   .84   1.0 (0.8-1.3)   .72  
Adjusted for age and sex     
    Noncarriers   1.0   .66   1.0   .83  
    Heterozygotes   0.9 (0.8-1.0)   .66   1.0 (0.8-1.2)   .83  
    Homozygotes
 
1.0 (0.9-1.3)
 
.66
 
1.0 (0.7-1.3)
 
.83
 

Odds ratios with 95% confidence intervals (CI) were calculated with noncarriers versus heterozygotes or homozygotes using unconditional logistic regression. P values are for trend tests, from noncarriers to heterozygotes to homozygotes. There were 2125 cases of IHD, 836 cases of ICVD, and 7568 controls.

or Create an Account

Close Modal
Close Modal